OPTIMIZIMG OF MANAGEMENT OF THE OVARIAN CANCER PATIENTS WITH PERITONEAL CARCINOMATOSIS
DOI:
https://doi.org/10.30888/2663-5712.2024-23-00-014Keywords:
Ovarian cancer, carcinomatosis, treatment, chemotherapy, HIPECAbstract
Objective: At present, common forms of cancer of different localization can not be ignored. New approaches to the treatment of metastatic lesions have some success in clinical application. This study is devoted to the experience of using the technology ofMetrics
References
Rybin AI, Demidchik RYa. Quality of life of patients with ovarian cancer after cytoreductive surgery and chemotherapy. Аctual problems of transport medicine 2018; 4 (54): 59–63. http://dx.doi.org/10.5281/zenodo.2525786
Tkachenko ОІ, Rybin AI, Kuznetsova OV, Maximovsky VE. Modern strategies of surgical treatment of patients with ovarian cancer combined with pelvic carcinomatosis. Clin oncol 2018; 8 (3): 1–7. https://repo.odmu.edu.ua:443/xmlui/handle/123456789/7250.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394-424. https://doi.org/10.3322/caac.21492.
Rybin AI, Kuznetsova OV, Maximovsky VE. Modern strategies of surgical treatment of patients with pelvic canceromatosis caused by the ovarian cancer. Visnyk morsʹkoyi medytsyny 2020; 2 (87): 55–61. http://dx.doi.org/10.5281/zenodo.3967728.
Rybin AI. The results of personificated ovarian cancer patients with peritoneal carcinomatosis treatment. Reproductive health of woman 2022; (7): 35–40. https://doi.org/10.30841/2708-8731.7.2022.272470.
Bondar O, Rybin A. The experience and results of cytoreductive surgery and HIPEC used in advanced ovarian cancer. ScienceRise 2020; (5): 19–23. https://doi.org/10.21303/2313-8416.2020.001458.
Di Vita M, Cappellani A, Piccolo G, et al. The role of HIPEC in the treatment of peritoneal carcinomatosis from gastric cancer: between lights and shadows. Anticancer Drugs 2015; 26 (2):123–38. https://doi.org/10.1097/cad.0000000000000179.
Santillan A, Karam AK, Li AJ, et al. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Gynecol Oncol 2007; 104 (3): 686–90. https://doi.org/10.1016/j.ygyno.2006.10.020.
Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221 (1): 29–42. https://doi.org/10.1097/00000658-199501000-00004.
Bondar O, Rybin A, Patskov A. The quality of life of ovarian cancer patients as an indication of effectiveness of platinum-based adjuvant chemotherapy. Georgian medical news 2021; (11): 32–6. https://repo.odmu.edu.ua:443/xmlui/handle/123456789/10608.
Cortez AJ, Tudre P, Kujawa KA, Lisowska KM. Advances in ovarian cancer therapy. Cancer Chemother Pharmacol 2018; 81 (1): 17–38. doi: 10.1007/s00280-017-3501-8.
Deraco M, Baratti D, Kusamura S, et al. Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol 2009; 100 (4): 321–8. https://doi.org/10.1002/jso.21388.
Oncogynecology. Rybin AI, et al. (eds). Odessa: ONMedU, 2013. 200 p. http://repo.odmu.edu.ua:80/xmlui/handle/123456789/1299.
Deraco M, Kusamura S, Virzì S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multiinstitutional phase-II trial. Gynecol Oncol 2011; 122 (2): 215–20. https://doi.org/10.1016/j.ygyno.2011.05.004.
Deraco M, Virzì S, Iusco D, et al. Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study. BJOG 2012; 119 (7): 800–9. https://doi.org/10.1111/j.1471-0528.2011.03207.
DiabY, Muallem MZ. Targeted therapy in ovarian cancer. A comprehensive systematic review of literature. Anticancer Research 2017; 37 (6): 2809–15. doi: 10.21873/anticanres.11631.
Chandra A, Pius P, Nabeel M, et al. Ovariancancer: Current status and strategies for improving therapeutic outcomes. Cancer Med 2019; 8 (16): 7018–31. doi: 10.1002/cam4.2560/.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
